Drug Screening Market Expected to Reach $9,447 Million by 2023 | Key Player include Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and Express Diagnostics International Inc

As per another report distributed by Allied Market Research, titled, "Medication Screening Market by Products and Services, Sample Type, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the worldwide medication screening market was esteemed at $5,214 million out of 2016, and is anticipated to reach $9,447 million by 2023, developing at a CAGR of 8.7% from 2017 to 2023. North America held the biggest piece of the overall industry with in excess of 50% offer in 2016.

Download Now! Sample PDF Brochure @ www.alliedmarketresearch.com/request-sample/1070?utm_source=OPR

Drug screening is carried out to detect the presence of any illegal drug in the different biological samples such as blood or urine. Biological samples derived from the subject are tested under drug screening devices to diagnose the nature and amount of drug in the system. Drug screening manufacturers provide a wide range of high-tech equipment which is used by organizations and law enforcement agencies to check the presence of any illegal drug in the body. Drug screening devices have helped government officials, employers and schools to maintain a drug free and healthy environment for individuals.

Major factors driving the drug screening market are increase in drug consumption among youth, upsurge in consumption of alcohol and misuse of prescribed or illicit drugs by individuals. In addition, rise in awareness among the population in developing countries regarding adverse effects of drugs will help to boost the market growth. Further, governments of many developed and developing nations are raising funds to deal with increasing drug abuse and illegal drug trafficking, which will help to fuel the market growth.

Laboratory services are currently dominating the products and services segment and is expected dominate the market during the forecast period. It occupies more than three-fifths of the total market share because of need to hire trained professionals capable of performing drug tests.

In the sample type segment urine sample is currently holding maximum amount of market share at six-sevenths of the total market with a CAGR of 8.6% from 2017-2023. Hair sample is expected to grow at the highest CAGR of 12.6% from 2017-2023.

The end user segment is dominated by work place and school with over two-thirds of the market. Employees and students under drug influence result in reduced productivity and absenteeism. Increasing awareness among public has led to surge in personal drug screening devices usage and this segment is forecast to exhibit highest CAGR over the forecast period.

Key Findings of the Drug Screening Market:
• Under products & services equipment segment the rapid testing devices segment is projected to grow at the highest CAGR of 9.6% from 2017-2023 over the forecast period.
• Hair sample segment is poised to witness the fastest growth during the forecast period.
• Workplace and schools generated the highest revenue in 2016, and is expected to continue its dominance over the forecast period.
• North America dominated the global drug screening market over the analysis period, and is projected to grow at a CAGR of 8.1% from 2017-2023.
• Asia-Pacific drug screening market is an upcoming market and expected to generate new opportunities for market players.

In 2016, North America held five-ninths of the market share in global drug screening market, and is expected to continue this trend due its large amount of drug abuse and adoption of drug screening devices in the region. U.S. federal government is raising funds against illegal drug trafficking and driving the market in North America region. Asia-Pacific region is growing at a fastest CAGR in the forecast period due to increase in awareness regarding effects of drug abuse among developing countries. In addition, increase in investments in R&D by public and private sectors is also expected to boost the market growth.

The major companies in drug screening market include Alere, Inc., Drgerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and Express Diagnostics International Inc.

Check offers and discount on this report @ www.alliedmarketresearch.com/get-discount/1070?utm_source=OPR

About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.